Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Osteoporos Int. 2009 Mar 25;20(11):1921–1927. doi: 10.1007/s00198-009-0900-7

Table 1.

Proportion of Patients Screened or Treated for Osteoporosis, Evaluating Patients within Physician Groups and Individual Physicians

GIOP Dataset
n = 6,281 patients
SPOF Dataset
N = 779 patients
Physician Groups, n 1,296 66
Number of patients per group
     Median (Mean) 4 (4.9) 11 (11.8)
     Inter-quartile range 1 - 6 8 - 15
     Range 1 - 50 2 - 26
Receipt of BMD testing, %
     Median (Mean) 45 (49) n/a
     Inter-quartile range 25 - 64
     Range 8 - 100
Receipt of OP Rx, %
     Median (Mean) 33 (42) 30 (34)
     Inter-quartile range 25 - 50 20 - 43
     Range 6 - 100 0 - 100

Individual Physicians, n 2,096 246
Number of patients per group
     Median (Mean) 2 (3.0) 2 (3.2)
     Inter-quartile range 1 - 4 1 - 4
     Range 1 - 35 1 - 21
Receipt of BMD testing, %
     Median (Mean) 50 (62) n/a
     Interquartile range 33-100
     Range 9-100
Receipt of OP Rx, %
     Median (Mean) 50 (55) 22 (34)
     Interquartile range 25 - 50 0 - 60
     Range 7 - 100 0 - 100

GIOP = glucocorticoid induced osteoporosis; SPOF = secondary prevention of fractures

BMD = bone mineral density; OP Rx = prescription osteoporosis medication